Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAjantapharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Radico Khaitan, Idea, Voltas, Ajanta Pharma; sell Petronet LNG

      Sumeet Jain of Destimoney Securities is of the view that one may buy Idea Cellular with a target of Rs 109.

    • Buy NALCO, Kotak Mahindra Bank, Indiabulls Real Estate, Jet Airways, ONGC, Ajanta Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying NALCO, Kotak Mahindra Bank, Indiabulls Real Estate, Jet Airways, ONGC and Ajanta Pharma.

    • Buy Raymond, Kwality, GMDC, Bajaj Finance, Idea Cellular, Bombay Burmah: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Raymond, Kwality, GMDC, Bajaj Finance, Idea Cellular and Bombay Burmah.

    • Buy Divis Laboratories, Raymond: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com

    • Buy Reliance Industries, Indo Count Industries, Ajanta Pharma, RBL Bank; sell Tata Motors: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Reliance Industries, Indo Count Industries, Ajanta Pharma and RBL Bank and can sell Tata Motors.

    • Top buy & sell ideas by Ashwani Gujral,Mitessh Thakkar & Prakash Gaba for November 20

      Mitessh Thakkar 0f mitesshthakkar.com has a buy on Ajanta Pharma with a stop loss of Rs 1237, target of Rs 1360 and a buy on DLF with a stop loss of Rs 215, target of Rs 245.

    • Bull's Eye: Buy United Spirits, Eveready, Mindtree, Jubilant Food, Gati, Mindtree

      Sumeet Jain of Destimoney Securities is of the view that one may buy Polaris Consulting with a target of Rs 384.

    • Buy Titan, Ajanta Pharma: Sandeep Wagle

      Sandeep Wagle of powermywealth.com advises buying Titan Company and Ajanta Pharma.

    • Buy Maruti Suzuki, DLF, Ajanta Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Maruti Suzuki, DLF and Ajanta Pharma.

    • Buy Ajanta Pharma, Andhra Bank; sell GMR Infrastructure, Bharat Financial Inclusion: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Ajanta Pharma and Andhra Bank and can sell GMR Infrastructure and Bharat Financial Inclusion.

    • Short PNB, Can Fin Homes, Capital First; buy Hero MotoCorp, Ajanta Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell PNB, Can Fin Homes and Capital First and can buy Hero MotoCorp and Ajanta Pharma.

    • Bull's Eye: Buy Axis Bank, Ajanta Pharma, Ashok Leyland, Bata, Divis Lab

      Gaurav Ratnaparkhi of Sharekhan advises selling Oriental Bank of Commerce Future with a target of Rs 120.50.

    • Buy Tata Global Beverage, Divis Labs, Ajanta Pharma, Ujjivan Financial: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Tata Global Beverage, Divis Labs, Ajanta Pharma and Ujjivan Financial.

    • Buy Speciality Restaurants, Ajanta Pharma; sell IndusInd Bank: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Speciality Restaurants and Ajanta Pharma and can sell IndusInd Bank.

    • Sell Cummins India, L&T Finance; buy Ashok Leyland, Hexaware, Dalmia Bharat, Bata: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Cummins India and L&T Finance Holdings and can buy Ashok Leyland, Hexaware Technologies, Dalmia Bharat and Bata India.

    • Trust equities for your child’s future this Children’s day! 20 stocks which rose up to 37000% in 10 yrs

      A child would require a lump sum amount when he/she plans to do graduation and the amount collected from either investing in direct equities or via mutual funds would give much better returns compared to child plans offered by various insurance companies, suggest experts.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for November 3

      Ashwani Gujral of ashwanigujral.com suggests buying KNR Construction with a stop loss of Rs 270, target of Rs 287, a buy in Aurobindo Pharma with a stop loss of Rs 784, target of Rs 810 and a buy in JM Financial with a stop loss of Rs 168, target of Rs 182.

    • Buy Natco Pharma, Aurobindo Pharma, Ajanta Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Aurobindo Pharma and Ajanta Pharma.

    • Buy Biocon, Ajanta Pharma, Aurobindo Pharma; Infibeam likely to hit Rs 156: Rajat Bose

      Rajat Bose of rajatkbose.com suggests buying Biocon, Ajanta Pharma and Aurobindo Pharma November futures while he feels that Infibeam Incorporation is likely to hit Rs 156.

    • Buy Ajanta Pharma, Wockhardt, UPL, Bajaj Finance: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, Wockhardt, UPL and Bajaj Finance.

    • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for October 27

      Mitessh Thakkar of mitesshthakkar.com has recommends a buy on Mangalore Refinery and Petrochemicals which has a positive candlestick pattern with a stop loss of Rs 131 for target of Rs 140 while Ashwani Gujral of ashwanigujral.com has a buy on Maruti Suzuki with a stop loss of Rs 8000, target of Rs 8250.

    • Buy Coal India, DHFL, Hindustan Unilever, TVS Motor; sell Ajanta Pharma: Sudarshan Sukhani

      Sudarshan Sukhani, s2analytics.com is of the view that one can buy Coal India, Dewan Housing Finance Corporation, Hindustan Unilever and TVS Motor Company and can sell Ajanta Pharma.

    • Short Ajanta Pharma; buy IGL, Ashok Leyland: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Indraprastha Gas and Ashok Leyland.

    • Sell ICICI Bank, Jet Airways, DLF; buy Ajanta Pharma, Torrent Pharma: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell ICICI Bank, Jet Airways and DLF and advises buying Ajanta Pharma and Torrent Pharma.

    • Nifty likely to open lower; top 4 stocks to buy, sell today: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, the level of 10000 is a psychological support and resistance at 10180-10211. Bank Nifty on the other hand has support at 24600 and resistance at 25000.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347